Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein in Reducing Toxicity and Improving Efficacy of Intravesical Therapy for Bladder Cancer
NCT01489813Phase 2Completed
- Sponsor
- Emory University
- Start
- May 2017
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of genistein in bladder cancer, sponsored by Emory University. Started May 2017; status: completed.
02
Drugs
genistein
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01489813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489813.